Afatinib Terminated Phase 2 Trials for Lung Cancers Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02271906The ATTAIN Study: A Therapeutic Trial of Afatinib In the Neoadjuvant Setting